USA Today/Indianapolis Star: Drugmakers are facing an array of challenges, like lawsuits and patent losses, but also new opportunities including global growth and an expected surge in the number of U.S. residents with health insurance. Eli Lilly CEO John Lechleiter comments in a Q&A: "The...